TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins

This publication has 23 references indexed in Scilit:

• p130Cas mediates the transforming properties of the anaplastic lymphoma kinase
  Blood, 2005
• Pediatric Inflammatory Myofibroblastic Tumor with Late Metastasis to the Lung: Case Report and Review of the Literature
  Pediatric and Developmental Pathology, 2005
• Myofibroblastic Malignancies
  Advances in Anatomic Pathology, 2004
• Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells
  Oncogene, 2004
• Nuclear FGF-2 facilitates cell survival in vitro and during establishment of metastases
  Oncogene, 2004
• ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases
  Blood, 2003
• Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors
  Oncogene, 2003
• Inflammatory myofibroblastic tumor: a spinal case with aggressive clinical course and ALK overexpression
  Journal of Neurosurgery: Spine, 2003
• High‐molecular‐weight tropomyosins localize to the contractile rings of dividing CNS cells but are absent from malignant pediatric and adult CNS tumors
  Glia, 2003
• Translocations involving anaplastic lymphoma kinase (ALK)
  Oncogene, 2001